-
Illumina Joins NVIDIA’s Agentic AI Vision at J.P. Morgan Healthcare Conference
Jan 13 | Bio-IT World | Among the many partnerships and technical announcements that Jensen Huang made during his Monday morning presentation at the 43rd Annual J.P. Morgan Healthcare Conference, NVIDIA focused several on innovation within the healthcare and life sciences industry. More -
Many Looming Unknowns About AI Policies of Incoming Administration
Jan 09 | Bio-IT World | Looming uncertainties tied to the upcoming U.S. administration change will affect many key areas of artificial intelligence (AI) in 2025, according to Mark Dredze, interim deputy director for the Data Science and AI Institute at Johns Hopkins University. While a focus on deregulation appears likely, exactly how things will play out for AI governance and policy is anyone’s guess. More -
Medicines for Placental Disorders Working Their Way up the Species Ladder
Jan 08 | Bio-IT World | The placenta is a temporary but critical organ everyone needs to initiate their life, yet it remains one of the most understudied organs in human biology despite the possible lifelong health implications if anything it is supposed to do goes awry. More -
Trendspotting: Predictions for Bio-IT World in 2025
Jan 07 | Bio-IT World | 2024 was full of innovative ideas and achievements. We spoke with industry experts and leaders about what to anticipate in the new year. Here are the full trends and predictions, including more on AI/ML, multimodal data, drug discovery, new policies, spatial biology, and more. More -
Top Stories of 2024: Illumina, Pistoia Alliance, Generative AI, Sequencing, More
Jan 03 | Bio-IT World | Last year, the world of biotech achieved much with AI, sequencing, treatment development, and more. The Trends from the Trenches podcast also covered data management strategies, embracing change, and the technologies driving data-intensive science. To kick off the new year, here are the top stories and top podcast episodes of 2024 from Bio-IT World and Trends from the Trenches. More -
AI Can’t Fix Bad Data: Why Semantic Technologies Are Key to R&D Acceleration
Dec 30 | Bio-IT World | What role will AI play in the future of drug development, especially as novel therapeutic approaches such as precision medicine drive up the complexity and cost of research? Some industry headlines hype AI as a magic bullet, capable of cutting through the headwinds of slow development cycles, shifting regulations, and high rates of failure. For companies racing to reach the market with safe and compliant new drug products, this vision of AI is compelling—and it’s driving heavy investment. More -
BC Platform, University of Nottingham Partnership, Certis Oncology Launches AI Assistant, More
Dec 27 | Bio-IT World | BC Platforms enters an extended joint partnership with the University of Nottingham and Nottingham University Hospitals NHS Trust to provide data sharing platforms and tools; Certis Oncology Solutions launches CertisOI Assistant, an innovative chatbot tool ; and more. More -
Follow the Money: Teaching AI Physics, AI-Powered Digital Twins of Cells, More
Dec 23 | Bio-IT World | AQEMIA intends to teach its generative AI platform quantum-inspired, atomic-scale physics to transform drug discovery; DeepLife plans to develop AI-powered models of human cells, known as digital twins of cells, for drug discovery; and more. More -
Researchers Call for an Open AI Virtual Cell, Outline Challenges to Overcome
Dec 18 | Bio-IT World | In a Perspectives paper published last week in Cell, researchers from Stanford University, Genentech, and the Chan-Zuckerberg Initiative issued a call for AI to build a virtual cell. Technology is ripe for a biologically-valuable virtual cell, they say, outlining their views of the priorities and opportunities. More -
Renee Iacona on Why Future Scientists Need to Learn About Data Science
Dec 17 | Bio-IT World | It has been a momentous year for artificial intelligence and machine learning. AI models can simulate clinical trials, diagnose diseases early, and detect biomarkers, and there is still no shortage of innovative ideas. However, there are some concerns surrounding AI/ML that have also been at the forefront of the industry. The latest episode of Trends from the Trenches covers one of these concerns. More
Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and
data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!
Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
Listen today!